Articles

In 2023, FDA approved 55 new drugs never before approved or marketed in the U.S., known as “novel” drugs. We also made other important approval decisions, such as expanding the use or patient population of previously approved drugs.

ABOUT AUTHOR
Dr. R. S. Thakur
Former Secretary, Pharmacy Council of India.
Email : drramsthakur@gmail.com

ABOUT AUTHOR
Dr. R. S. Thakur
Renowned Professor of Pharmaceutical Fraternity &
Former Member of Pharmacy Council of India.
Email : drramsthakur@gmail.com

About Authors
CHETNA MODI¹*, VINIT MODI², SHWETA RAY², PIYUSH NARIYA², VARSHA GADHVI^2
1Professor, Department of Pharmaceutics, Anand Pharmacy College, Anand, Gujarat, India.
²Research Scholar, Department of Pharmaceutics, Anand Pharmacy College, Anand, Gujarat, India.
*chetnamodi306@gmail.com

About Author
Ramraj Choudhary M.Pharma, (Pharmaceutics)
Dr. H.S Gour University,  Sagar  MP
Current Position : Sr. Pharmacist, CGHS, MOHFW

ABOUT AUTHOR
Dr. R. S. Thakur
Chief Editor, Journal of Pharmaceutical Research
Krupanidhi College of Pharmacy, Bengaluru, India.
Email : drramsthakur@gmail.com

Vinay Kumar Singh.  
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

About Author
Ambika Shakya ,  Arabind kumar
Ambikashk9@gmail.com, arvindkumarshk@gmail.com
Kalka Institute For Research & Advanced Studies
NH-58, Baral, Partapur Bypass, Meerut-250103